Elsevier

Survey of Ophthalmology

Volume 41, Issue 2, September–October 1996, Pages 142-154
Survey of Ophthalmology

The spectrum of orbital aspergillosis: a clinicopathological review

https://doi.org/10.1016/S0039-6257(96)80004-XGet rights and content

Abstract

Orbital aspergillosis is an uncommon but serious infection that may first present to the ophthalmologist. Usually arising from the paranasal sinuses, it may present in manifold ways within the orbit. Some presentations, such as optic nerve involvement, can respond to systemic corticosteroids, leading to delays in diagnosis and possibly iatrogenic potentiation of the infectious process. In this review, pertinent clinical and radiographic findings are discussed, and the literature is summarized. Classic approaches to therapy include local treatment, debridement, and systemic amphotericin B. We review novel approaches to treating orbital aspergillosis and detail a flow-chart for its management. Four patients from the spectrum of orbital aspergillosis are also described: initially presenting as an infection of an exenteration socket, a complex dacryocystitis, an optic nerve tumor, and post-operative periorbital swelling. Physicians should be familiar with the clinical spectrum of disease and the variable presentation of this infection, as early diagnosis and rapid institution of appropriate therapy are crucial elements in the management of invasive aspergillosis. In the neutropenic or otherwise immunocompromised patient, a high index of suspicion must be maintained as delays in diagnosis of fulminant aspergillosis may lead to overwhelming and rapidly progressive infection. Obtaining adequate diagnostic material for pathological and microbiological examination is critical. Newer methods of therapy, particularly itraconazole and liposomal amphotericin B, may be beneficial in selected patients.

References (119)

  • RJ Hay

    Liposomal amphotericin B, AmBisome

    J Infect

    (1994)
  • PB Irby et al.

    Fungal bezoars of the upper urinary tract

    J Urol

    (1990)
  • GM Jeffery et al.

    Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients

    Am J Med

    (1991)
  • DG Kim et al.

    Cerebral aspergillosis in immunologically competent patients

    Surg Neurol

    (1993)
  • G Krennmair et al.

    Computed tomography (CT) in the diagnosis of sinus aspergillosis

    J Craniomaxillofac Surg

    (1994)
  • R Mouy et al.

    Incidence, severity, and prevention of infections in chronic granulomatous disease

    J Pediatr

    (1989)
  • R Mouy et al.

    Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease

    J Pediatr

    (1994)
  • O Olurin et al.

    Orbital histoplasmosis due to Histoplasma duboisii

    Am J Ophthalmol

    (1969)
  • PJ Patel et al.

    CT findings in paranasal aspergillosis

    Clin Radiol

    (1992)
  • HT Rodenbiker et al.

    Ocular coccidioidomycosis

    Surv Ophthalmol

    (1980)
  • JG Rogers et al.

    Aspergillus myocarditis presenting as myocardial infarction with complete heart block

    Am Heart J

    (1990)
  • MA Rudwan et al.

    Aspergilloma of paranasal sinuses—a common cause of unilateral proptosis in Sudan

    Clin Radiol

    (1976)
  • AL Allphin et al.

    Allergic fungal sinusitis: problems in diagnosis and treatment

    Laryngoscope

    (1991)
  • PM Arnow et al.

    Pulmonary aspergillosis during hospital renovation

    Am Rev Respir Dis

    (1978)
  • BC Ashdown et al.

    Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings

    Am J Roentgenol

    (1994)
  • P Austin et al.

    Orbital aspergillosis. Report of a case diagnosed by fine needle aspiration biopsy

    Acta Cytol

    (1983)
  • JE Bennett

    Antifungal agents

  • JE Bennett

    Aspergillus species

  • BJ Bernhisel et al.

    Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease

    J Infect Dis

    (1991)
  • GP Bodey et al.

    Aspergillosis

    Eur J Clin Microbiol Infect Dis

    (1989)
  • B Boes et al.

    Central nervous system aspergillosis. Analysis of 26 patients

    J Neuroimaging

    (1994)
  • MA Boogaerts et al.

    Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

    Mycoses

    (1989)
  • M Borgers et al.

    Mode of action of itraconazole: morphological aspects

    Mycoses

    (1989)
  • R Breadmore et al.

    Intracranial aspergillosis producing cavernous sinus syndrome and rupture of internal carotid artery

    Australas Radiol

    (1994)
  • AE Brown

    Overview of fungal infections in cancer patients

    Semin Oncol

    (1990)
  • P Brown et al.

    Neuro-ophthalmological presentation of non-invasive Aspergillus sinus disease in the non-immunocompromised host

    J Neurol Neurosurg Psychiatry

    (1994)
  • PA Burch et al.

    Favorable outcome of invasive aspergillosis in patients with acute leukemia

    J Clin Oncol

    (1987)
  • KV Cahill et al.

    Intraorbital injection of amphotericin B for palliative treatment of Aspergillus orbital abscess

    Ophthal Plast Reconstr Surg

    (1994)
  • Case Records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-1991. A 74-year-old man with severe vascular disease, chronic lymphocytic leukemia, and loss of vision in the left eye

    N Engl J Med

    (1991)
  • JA Como et al.

    Oral azole drugs as systemic antifungal therapy

    N Engl J Med

    (1994)
  • YF Cudennec et al.

    Isolated sphenoidal aspergillosis presenting as an optic neuropathy

    Rev Laryngol Otol Rhinol (Bord)

    (1990)
  • M Cunningham et al.

    Necrotizing otitis externa due to Aspergillus in an immunocompetent individual

    Arch Otol Head Neck Surg

    (1988)
  • CF Decker et al.

    Invasive aspergillosis in patients with HIV infection: report of two patients and a review of the literature

    J Acquir Immune Defic Syndr

    (1991)
  • DW Denning et al.

    Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases

    Rev Infect Dis

    (1990)
  • RK Dortzbach et al.

    Orbital aspergillosis

    Ophthalmic Surg

    (1983)
  • PE Drakos et al.

    Invasive fungal sinusitis in patients undergoing bone marrow transplantation

    Bone Marrow Transplant

    (1993)
  • ME Dyken et al.

    Carotid-cavernous sinus thrombosis caused by Aspergillus fumigatus: magnetic resonance imaging with pathologic correlation—a case report

    Angiology

    (1990)
  • SS Fernando et al.

    Aspergillus fumigatus infection of the optic nerve with mycotic arteritis of cerebral vessels

    Histopathology

    (1982)
  • T Freilich

    Aspergilloma producing painful ophthalmoplegia

    N Y State J Med

    (1986)
  • GC Friedman et al.

    Allergic fungal sinusitis. Report of three cases associated with dematiaceous fungi

    Am J Clin Pathol

    (1991)
  • Cited by (128)

    • Fungi of the human eye: Culture to mycobiome

      2022, Experimental Eye Research
    • Voriconazole in the treatment of invasive aspergillosis of orbit

      2022, Medical Journal Armed Forces India
      Citation Excerpt :

      The microbiological analysis demonstrated A. flavus as the etiological agent in all the cases in our study. Studies from the western countries have reported Aspergillus fumigatus as the predominant causative agent, while studies from Asia report A. flavus as the main cause, as is also evident in our study.2,3,14,15 In another study, authors proposed that A. flavus may be commonly found in immunocompetent patients, whereas A. fumigatus may be associated with an immunocompromised condition of the patients.16,17

    • Orbital Disease in Neuro-Ophthalmology

      2018, Liu, Volpe, and Galetta's Neuro-Ophthalmology: Diagnosis and Management
    View all citing articles on Scopus

    The authors have no financial interest in any drug mentioned in this article. Funded in part by Research to Prevent Blindness, Inc.

    View full text